We are live on
!
Find out more
MYOK
MyoKardia, Inc. Common Stock
MYOK
MYOK
Delisted
MYOK was delisted on the 16th of November, 2020.
157 hedge funds and large institutions have $2.55B invested in MyoKardia, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 57 increasing their positions, 47 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
21% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 47
13% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 23
7% more capital invested
Capital invested by funds: $2.39B → $2.55B (+$161M)
1% more funds holding
Funds holding: 155 → 157 (+2)
19% less call options, than puts
Call options by funds: $4.77M | Put options by funds: $5.89M
Holders
157
Holders Change
+2
Holders Change %
+1.29%
% of All Funds
3.44%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.18%
New
26
Increased
57
Reduced
47
Closed
23
Calls
$4.77M
Puts
$5.89M
Net Calls
-$1.12M
Net Calls Change
+$524K
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$26.6M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$17.2M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
+$15.2M |
| 4 |
BlackRock
New York
|
+$14.6M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$9.56M |
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$29.2M |
| 2 |
Millennium Management
New York
|
-$13.1M |
| 3 |
O
OrbiMed
New York
|
-$9.16M |
| 4 |
CC
Casdin Capital
New York
|
-$9.04M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$7.02M |
